|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
10 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating and formation expenses | |||||
| Loss from operations | |||||
| Unrealized gain on investments held in Trust Account | |||||
| Other (expense) income: | |||||
| Income from cash held in the Trust Account | |||||
| Interest (expense) on operating cash account | |||||
| Gain on forfeiture of deferred underwriting fee payable | |||||
| Benefit from credit loss | |||||
| Change in fair value of derivative warrant liabilities | |||||
| Total other (expense) income, net | |||||
| Net loss | |||||
| Weighted average shares outstanding - basic (in shares) | |||||
| Class A ordinary shares subject to possible redemption | |||||
| Class A (non-redeemable) and Class B Ordinary Shares | |||||
| Weighted average shares outstanding - diluted (in shares) | |||||
| Class A ordinary shares subject to possible redemption | |||||
| Class A (non-redeemable) and Class B Ordinary Shares | |||||
| Net loss per share - basic (in dollars per share) | |||||
| Net loss per share - diluted (in dollars per share) | |||||
Loading...